Rigel Pharmaceuticals RIGL Balance Sheet (2010-2026)

NASDAQ RIGL
$43.91 +1.86 (+4.42%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Rigel Pharmaceuticals Quarterly Balance Sheet

Periods 66 quarters
Latest Sep 2026

Rigel Pharmaceuticals reported total assets of $523.88M and total liabilities of $78.77M for the quarter ended Sep 2026, up 116.0% year over year. This balance sheet covers 66 quarters of results from Jun 2010 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
18.89M24.68M27.20M29.87M24.46M40.29M48.81M45.41M32.79M25.57M36.05M51.69M56.75M45.73M53.41M48.53M40.58M24.41M60.82M46.65M
Short-term InvestmentsInvestments (Current)
106.08M82.84M61.97M51.78M33.75M18.38M15.55M16.94M24.15M23.98M13.05M9.42M20.58M31.37M54.97M88.61M114.38M122.27M34.51M52.66M
Cash & Current Investments
124.97M107.52M89.17M81.64M58.21M58.66M64.36M62.35M56.93M49.55M49.10M61.11M77.32M77.10M108.38M137.14M154.96M146.68M95.33M99.31M
Receivables - NetNet Receivables
15.47M15.24M17.20M15.53M20.00M29.37M20.82M23.55M30.55M27.51M28.90M30.58M41.62M41.55M39.91M45.93M51.76M49.95M56.04M56.46M
Receivables
15.47M15.24M17.20M15.53M20.00M29.37M20.82M23.55M30.55M27.51M28.90M30.58M41.62M41.55M39.91M45.93M51.76M49.95M56.04M56.46M
Raw Materials
5.14M4.56M4.56M4.56M4.56M6.91M6.88M4.61M3.92M2.15M1.57M1.08M1.08M9.63M6.95M4.51M3.43M7.23M7.34M
Work In Process
0.16M1.04M0.57M1.24M2.66M2.05M2.05M1.88M5.12M6.01M1.81M1.23M1.11M2.03M5.49M3.91M6.23M7.00M6.77M
Finished Goods
1.31M1.17M1.09M1.32M1.90M2.12M1.86M1.51M1.28M4.37M5.83M5.01M3.76M2.71M1.79M4.71M4.10M2.84M7.20M
Inventory
6.62M6.76M6.22M7.12M9.12M11.08M10.78M6.11M5.52M6.58M8.06M4.78M6.00M4.66M10.42M13.30M11.51M11.65M14.37M15.81M
Prepaid Assets
7.41M9.42M7.94M6.16M8.26M7.87M4.97M3.02M6.26M8.85M8.66M9.99M10.17M23.26M16.68M18.56M21.94M25.75M19.79M16.96M
Current Assets
154.47M138.94M120.52M110.44M115.90M106.97M100.93M95.02M99.27M92.49M94.72M106.47M135.10M146.56M175.39M214.93M240.17M234.03M185.53M188.52M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
2.18M2.14M1.83M1.69M0.86M0.29M0.22M0.19M0.17M0.14M0.12M0.10M0.09M0.08M0.06M0.05M
Goodwill & Intangibles
14.95M14.68M14.41M14.15M13.88M28.86M28.28M27.69M27.10M26.51M25.92M25.34M24.75M24.16M93.88M94.59M
Long-Term Deferred Tax
245.85M243.28M238.07M234.53M
Other Non-Current Assets
0.97M0.46M0.40M0.48M0.64M0.54M0.54M4.96M3.06M4.32M4.74M4.76M1.53M1.52M4.18M1.17M1.91M2.36M2.94M5.74M
Non-Current Assets
12.86M10.14M7.48M5.17M18.38M16.64M16.17M20.30M17.96M34.03M33.69M32.95M28.87M29.41M31.34M27.61M273.43M270.58M335.54M335.35M
Assets
167.33M149.07M128.00M115.61M134.28M123.61M117.09M115.32M117.23M126.52M128.41M139.42M163.98M175.97M206.74M242.53M513.59M504.61M521.07M523.88M
Liabilities
Current Liabilities
Accounts Payables
3.80M4.61M2.16M2.72M22.51M6.30M5.24M8.00M7.14M9.28M6.13M3.82M3.34M3.95M7.29M3.85M7.19M4.49M4.01M11.44M
Payables
3.80M4.61M2.16M2.72M22.51M6.30M5.24M8.00M7.14M9.28M6.13M3.82M3.34M3.95M7.29M3.85M7.19M4.49M4.01M11.44M
Other Accumulated Expenses
13.51M16.51M16.89M17.60M6.49M5.62M5.70M5.03M5.33M5.44M5.93M9.97M11.75M7.44M8.59M8.94M11.47M9.67M7.95M11.07M
Short term Debt
7.23M14.78M7.27M14.82M22.36M29.76M29.81M29.87M39.24M7.24M
Current Leases
Current Deferred Revenue
2.60M2.10M1.54M1.37M1.37M1.37M1.36M1.36M1.36M1.36M1.36M1.36M1.36M1.36M1.36M1.36M
Total Current Liabilities
63.55M59.23M54.96M47.27M65.21M45.52M44.02M48.27M53.27M73.20M58.65M54.31M63.30M66.63M86.64M94.40M99.24M89.49M95.59M78.77M
Non-Current Liabilities
Capital Leases
Non-Current Debt
19.91M29.85M29.84M39.47M39.45M59.48M59.57M59.66M52.37M44.91M59.69M59.76M59.68M44.93M37.45M29.97M52.29M44.86M39.24M7.24M
Non-Current Deferred Revenue
Operating Leases
0.76M0.97M0.80M0.63M0.47M0.29M0.10M0.86M0.71M0.56M0.40M0.23M0.06M
Other Non-Current Liabilities
52.73M53.20M46.89M48.71M42.26M42.07M40.98M38.76M39.94M15.22M15.00M5.00M44.98M49.98M5.00M5.00M
Total Non-Current Liabilities
84.23M89.07M84.79M86.73M105.63M105.80M104.23M108.40M105.93M142.97M143.32M149.06M115.71M107.42M119.80M119.93M122.11M
Total Liabilities
136.95M142.28M131.68M135.44M147.90M147.87M145.21M147.16M145.87M158.19M158.32M154.06M160.69M157.41M124.80M124.93M122.11M104.71M95.64M78.77M
Shareholder's Equity
Total Debt
19.91M29.85M29.84M39.47M39.45M59.48M59.57M59.66M59.60M59.69M59.69M59.76M66.95M59.75M59.81M59.73M82.11M74.72M78.47M14.47M
Common Equity
30.37M6.80M-3.68M-19.83M-13.62M-24.26M-28.12M-31.83M-28.64M-31.67M-29.91M-14.64M3.29M18.57M81.93M117.61M391.48M399.90M425.42M445.11M
Liabilities and Shareholders Equity
167.33M149.07M128.00M115.61M134.28M123.61M117.09M115.32M117.23M126.52M128.41M139.42M163.98M175.97M206.74M242.53M513.59M504.61M521.07M523.88M
Retained Earnings
-1,323.89M-1,351.33M-1,364.82M-1,383.86M-1,382.46M-1,396.00M-1,402.60M-1,408.29M-1,407.55M-1,415.80M-1,416.83M-1,404.41M-1,390.07M-1,378.62M-1,319.01M-1,291.11M-1,023.04M-1,014.39M-997.10M-983.91M

Rigel Pharmaceuticals Balance Sheet API

Pull Rigel Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RIGL&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY